These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 39352393)

  • 1. Clonal hematopoiesis and hematological malignancy.
    Dunn WG; McLoughlin MA; Vassiliou GS
    J Clin Invest; 2024 Oct; 134(19):. PubMed ID: 39352393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
    Hartmann L; Metzeler KH
    Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiology of hematological malignancies associated with ASXL1 mutations].
    Fujino T
    Rinsho Ketsueki; 2022; 63(6):561-572. PubMed ID: 35831189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?
    Steensma DP
    Best Pract Res Clin Haematol; 2021 Dec; 34(4):101327. PubMed ID: 34865699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms.
    Pegliasco J; Hirsch P; Marzac C; Isnard F; Meniane JC; Deswarte C; Pellet P; Lemaitre C; Leroy G; Rabadan Moraes G; Guermouche H; Schmaltz-Panneau B; Pasquier F; Colas C; Benusiglio PR; Bera O; Bourhis JH; Brissot E; Caron O; Chraibi S; Cony-Makhoul P; Delaunay-Darivon C; Lapusan S; de Fontbrune FS; Fuseau P; Najman A; Vainchenker W; Delhommeau F; Micol JB; Plo I; Bellanné-Chantelot C
    Leukemia; 2022 Jan; 36(1):126-137. PubMed ID: 34172895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms.
    Xie Z; Chen EC; Mendez LM; Komrokji R; Zeidan AM
    Cancer J; 2023 May-Jun 01; 29(3):130-137. PubMed ID: 37195768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TFH lymphoma and associated clonal hematopoiesis].
    Nann D; Fend F; Quintanilla-Martinez L
    Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):144-149. PubMed ID: 37870568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASXL1 mutation in clonal hematopoiesis.
    Fujino T; Kitamura T
    Exp Hematol; 2020 Mar; 83():74-84. PubMed ID: 31945396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.
    von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A
    Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies.
    Ye B; Sheng Y; Zhang M; Hu Y; Huang H
    Cancer Lett; 2022 Jul; 538():215691. PubMed ID: 35469959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Origin of Clonal Hematopoiesis and Its Implication in Human Diseases.
    Zhang Z; Sun J
    Adv Exp Med Biol; 2023; 1442():65-83. PubMed ID: 38228959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal Hematopoiesis and risk of Acute Myeloid Leukemia.
    Desai P; Hassane D; Roboz GJ
    Best Pract Res Clin Haematol; 2019 Jun; 32(2):177-185. PubMed ID: 31203999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Pathology of Myeloid Neoplasms: Molecular Pattern Recognition.
    Sadigh S; Kim AS
    Clin Lab Med; 2024 Jun; 44(2):339-353. PubMed ID: 38821648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Challenge and Clinical Dilemma: The Long Reach of Clonal Hematopoiesis.
    Osman A; Patel JL
    Clin Chem; 2021 Aug; 67(8):1062-1070. PubMed ID: 34263288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation.
    Goldman EA; Spellman PT; Agarwal A
    Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 36889927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications.
    Malcovati L; Ambaglio I; Elena C
    Curr Opin Oncol; 2015 Nov; 27(6):551-9. PubMed ID: 26352542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal hematopoiesis and inflammation: A review of mechanisms and clinical implications.
    Nathan DI; Dougherty M; Bhatta M; Mascarenhas J; Marcellino BK
    Crit Rev Oncol Hematol; 2023 Dec; 192():104187. PubMed ID: 37879493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia.
    Higgins A; Shah MV
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32640569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms.
    Loghavi S; Wang SA
    Surg Pathol Clin; 2019 Sep; 12(3):651-669. PubMed ID: 31352979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Precursors of acute leukemia: myelodysplastic syndromes and myeloproliferative neoplasms].
    Kreipe HH
    Pathologe; 2011 Nov; 32 Suppl 2():271-6. PubMed ID: 22033685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.